期刊文献+

CCA法与FMEA法在制药纯化水分配系统风险评估中的应用 被引量:6

Application of CCA and FMEA in Risk Assessment of Pharmaceutical Purified Water Distribution System
原文传递
导出
摘要 目的:提高制药企业纯化水分配系统风险管理效率,节约企业资源,降低企业成本。方法:结合南京某制药有限公司纯化水分配系统实例,运用部件关键性评估(CCA)法选出直接影响系统的关键部件,然后运用质量风险管理工具失效模式与影响分析(FMEA)法对其进行风险评估并提出风险管控措施。结果与结论:通过运用CCA法判定标准,可选出直接影响纯化水分配系统的关键部件;通过建立FMEA法评分标准和风险级别判定标准,运用FMEA法风险评估表可对关键部件进行风险评估并制定相应的风险管控措施。两种方法既可提高风险管理效率,也能降低企业成本。但同时,运用FMEA法定量评估风险也存在一定的主观性;以风险优先度(RPN)值来衡量失效模式的风险顺序进而确定改善措施的优先等级,在实际工作运行时存在一定的问题。因此,需结合其他风险管理工具作进一步研究。 OBJECTIVE:To improve the efficiency of purified water distribution system's risk management in pharmaceutical enterprise,save resources and reduce enterprise cost. METHODS:According to the instance of purified water distribution system in a pharmaceutical Co.,Ltd. in Nanjing,components critical evaluation(CCA)method was conducted to select the critical components;and failure mode and effects analysis(FMEA)method with quality of risk management tools was conducted to evaluate the risk assessment and put out control measures. RESULTS CONCLUSIONS:The critical components with direct effects on the purified water distribution system could be selected through the CCA standards. The FMEA standards of scoring and level risk criteria and the risk assessment tables were used to evaluate the risk assessment and formulate the risk control measures. It not only enhanced risk management efficiency,but also reduced enterprise cost. However,the application of FMEA on risk quantitative evaluation has certain subjectivity;it remains certain problems in the practical work about RPN values to measure the risk orders of failure mode and to determine the priority levels of improvements. Therefore,it needs further study with the combination of other risk management tools.
作者 梁毅 丁恩伟
出处 《中国药房》 CAS 北大核心 2015年第10期1306-1308,共3页 China Pharmacy
关键词 部件关键性评估法 失效模式与影响分析 纯化水分配系统 风险评估 Components critical evaluation Failure mode and effects analysis Purified water distribution system Risk assess-ment
  • 相关文献

参考文献14

二级参考文献60

  • 1庄华玲,李艳芳,吴国盛.纯化水微生物限度检查方法的商榷[J].中国药师,2006,9(10):975-975. 被引量:8
  • 2王弘,郭代红,刘皈阳.湿法制粒工序参数的应用进展[J].中国新药杂志,2007,16(5):361-365. 被引量:17
  • 3黄健宇.论FMEA的分析与应用[J].机械工业标准化与质量,2007(4):37-41. 被引量:8
  • 4国家食品药品监督管理局药品监管安全司等组织编写.药品生产质量管理规范(2010年修订)培训教材[M].天津:天津科学技术出版社,2011:393-394.
  • 5International Standard. Analysis techniques for systemreliability- Procedure for failure mode and effects analysis (FMEA) [S]. IEC 60812: 2006.
  • 6EU guidelines to good manufacturing practice medicinal products for human and veterinary use, Annex 20, Quality Risk Management[S]. Brussels, 2008: 14.
  • 7崔福德.药剂学[M].北京:人民卫生出版社,2011:96.
  • 8刘易斯.项目经理案头手册(王增东等译)[M].北京:机械工业出版社,2001..
  • 9卢有杰 卢家仪.项目风险管理[M].北京:机械工业出版社,2001..
  • 10凯文·福斯伯格 哈尔·穆兹 霍华德·科特曼(刘景梅 许江林 于军译).可视化项目管理[M].北京:电子工业出版社,2002..

共引文献143

同被引文献30

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部